Heqet Therapeutics announced it has received £6.6 million in its series A round of funding led by new investors Claris Ventures SGR SpA and 2Invest AG on March 23, 2022. As part of the transaction Pietro Puglisi of Claris Ventures SGR SpA, Heikki Lanckriet of 2Invest, will join the board of the company as directors. The company issued common stock in the transaction.